Clinical guidelines for cryoprecipitate transfusions

Author:

Galstyan G. M.1ORCID,Gaponova T. V.1ORCID,Zhiburt E. B.2ORCID,Balashova E. N.3ORCID,Berkovskiy A. L.1ORCID,Bystrykh O. A.3ORCID,Kupryashov A. A.4ORCID,Olovnikova N. I.1ORCID,Oshorov A. V.5ORCID,Rybka M. M.4ORCID,Troitskaya V. V.1ORCID,Bulanov A. Yu.6,Zhuravel S. V.7ORCID,Lubnin A. Yu.5ORCID,Mazurok V. A.8ORCID,Nedomolkin S. V.9ORCID,Pevtcov D. E.10ORCID,Rogachevskiy O. V.3ORCID,Salimov E. L.11ORCID,Trakhtman P. E.12ORCID,Chzhao A. V.13ORCID,Sherstnev F. S.14ORCID,Savchenko V. G.1ORCID

Affiliation:

1. National Research Center for Hematology

2. Pirogov National Medical and Surgical Center

3. V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology

4. Bakoulev Scientific Center for Cardiovascular Surgery

5. Burdenko Neurosurgery Institute

6. Moscow City municipal hospital 52

7. N.V. Sklifosovsky Research Institute of Emergency Medicine

8. Almazov National Medical Research Centre

9. S.M. Kirov Military Medical Academy

10. I.P. Pavlov First Saint Petersburg State Medical University

11. I.M. Sechenov First Moscow State Medical University

12. Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology

13. A.V. Vishnevsky National Medical Research Center of Surgery

14. Kirov Research Institute of Hematology and Blood Transfusion

Abstract

Background. Cryoprecipitate is made from fresh-frozen plasma (FFP) and contains fibrinogen, factor VIII, factor XIII, von Willebrand factor, fibronectin and fibrinogen.Aim. To provide information on the composition and methods of production, storage, transportation and clinical use of cryoprecipitate.General findings. Cyoprecipitate is manufactured by slowly thawing FFP at 1–6°C. This precipitates out cryoproteins: factor VIII, von Willebrand factor, factor XIII, fibronectin and fibrinogen. After centrifugation, the cryoproteins are resuspended in a reduced volume of plasma. Cryoprecipitate is stored at temperatures not exceeding –25° С for 36 months. Indications for cryoprecipitate transfusion are hemophilia A, von Willebrand disease, factor XIII deficiency, congenital afibrinogenemia and hypofibrinogenemia, acquired hypofibrinogenemia. These indications can occur in obstetrics, neonatology, cardiac surgery, neurosurgery, hematology, orthopaedics, and general surgery during liver transplantation and disseminated intravascular coagulation.

Publisher

National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation

Subject

Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3